Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Emphysema, Mediastinal

fluorodeoxyglucose f18 has been researched along with Emphysema, Mediastinal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Aslan, B; Dilbil, M; Erbasan, F; Nokay, M; Öğüt, TS; Terzioğlu, ME; Yazısız, V1
Fernandes, F; Paupério, G; Rodrigues, A1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Emphysema, Mediastinal

ArticleYear
Pneumomediastinum, pneumatosis intestinalis and pneumoperitoneum in a patient with polymyositis: case-based review.
    Rheumatology international, 2023, Volume: 43, Issue:4

    Topics: Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Mediastinal Emphysema; Middle Aged; Myositis; Pneumatosis Cystoides Intestinalis; Pneumoperitoneum; Polymyositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Remission, Spontaneous

2023
Pneumomediastinum: A Brief Review Of Literature Apropos Of A Case Report.
    Portuguese journal of cardiac thoracic and vascular surgery, 2022, Oct-05, Volume: 29, Issue:3

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Emphysema; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2022